Bruce Bernstein
CIK 1665472 · last filed 2026-07-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$966.3K
Companies
11
Total Filings
84
Lifetime Open-Market Net
$445.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WRAP | Director | 250,848 | $1.73 | $434.0K | $0 | 20 | 2026-07-06 |
| TAOX | Director | 30,897 | $3.38 | $104.4K | $0 | 4 | 2026-05-19 |
| RREVU | Director | — | — | — | $0 | 1 | 2026-05-05 |
| QCLS | Director | 25,000 | $2.84 | $71.0K | $0 | 2 | 2026-04-15 |
| XWEL | Director | 339,882 | $1.05 | $356.9K | $21.1K | 6 | 2026-03-02 |
| TAO Synergies Inc. (SNPX) Delisted | Director | 1,103 | $24.55 | $27.1K | -$26.4K | 9 | 2025-04-07 |
| Petros Pharmaceuticals, Inc. (PTPI) Delisted | Director | 12,334 | $0.01 | $76 | $0 | 8 | 2025-02-21 |
| XWELL, Inc. (XSPA) Delisted | Director | 729,198 | $0.66 | $477.6K | $332.7K | 13 | 2022-03-21 |
| NTRP | Director | 0 | $1.64 | $0 | $0 | 6 | 2020-12-03 |
| XWELL, Inc. (FH) Delisted | Director | 788,290 | — | — | $117.6K | 8 | 2017-08-21 |
| XWELL, Inc. (VRNG) Delisted | Director | — | — | — | $0 | 1 | 2016-04-06 |
Recent Filings · Page 3 of 9
84 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-21 | Petros Pharmaceuticals, Inc. (PTPI) Delisted | Grant (A) | +300,000 | $0 | EDGAR |
| 2025-02-13 | WRAP | Grant (A) | +14,142 | $0 | EDGAR |
| 2025-01-06 | WRAP | Grant (A) | +14,269 | $0 | EDGAR |
| 2024-11-18 | XWEL | Grant (A) | — | $0 | EDGAR |
| 2024-10-03 | WRAP | Grant (A) | +20,167 | $0 | EDGAR |
| 2024-07-03 | WRAP | Grant (A) | +15,125 | $0 | EDGAR |
| 2024-04-10 | TAO Synergies Inc. (SNPX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-04-03 | WRAP | Grant (A) | +13,385 | $0 | EDGAR |
| 2024-01-18 | WRAP | Grant (A) | +9,758 | $0 | EDGAR |
| 2024-01-18 | WRAP | Grant (A) | +4,786 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.